Innoviva, Inc.

INVA

Innoviva, Inc.

INVA

Insider Sentiment (TTM):

Last Purchase:2023-06-15Last Sale:2025-03-06Shares Purchased (TTM):0Shares Sold (TTM):0

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:73,695,084Shares Outstanding:74,160,000Institutional Ownership Pct.:99.37%

Earnings Market Reaction:

Filing Date:2026-08-05Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value	570	603	551	477	398	319	305	261	217	178	194	180
Accounts Receivable Net	51	34	35	30	21	17	20	31	27	14	14	11
Receivables Long Term Contracts Or Programs	60	59	58	63	67	61	66	61	67	62	70	57
Inventory Net	39	39	39	38	49	41	34	34	37	37	41	41
Prepaid Expense And Other Assets Current	24	25	27	19	17	15	21	13	8	17	22	15
Other Assets Current	0	4	2	0	0	0	1	2	2	3	4	2
Assets Current	753	773	728	685	652	582	554	401	358	311	344	305
Property Plant And Equipment Net	2	2	2	2	0	0	1	1	0	0	0	0
Long Term Investments	441	413	404	344	297	291	342	434	445	477	444	422
Capitalized Contract Cost Net	49	53	56	60	63	67	70	73	77	80	84	87
Operating Lease Right Of Use Asset	10	11	11	1	2	2	2	3	3	2	3	3
Goodwill	18	18	18	18	18	18	18	18	18	18	18	18
Intangible Assets Net Excluding Goodwill	169	176	182	189	195	202	208	211	217	224	230	237
Deferred Income Tax Assets Net	-	-	0	8	13	12	12	15	11	-	0	5
Other Assets Noncurrent	40	41	41	41	41	41	41	3	3	3	3	3
Assets	1,703	1,837	1,635	1,429	1,334	1,254	1,301	1,232	1,225	1,268	1,244	1,188
Liabilities And Stockhold…
Liabilities Current
Accounts Payable Current	4	7	5	6	5	5	2	4	2	1	7	4
Employee Related Liabilities Current	7	4	9	7	5	4	7	6	5	3	7	5
Interest Payable Current	2	0	2	0	3	1	3	1	3	1	3	1
Deferred Revenue Current	6	4	4	14	3	1	1	1	1	1	1	2
Convertible Debt Current	-	-	-	-	-	-	-	192	-	-	0	0
Accrued Income Taxes Current	0	0	0	-	-	2	0	3	-	-	0	0
Debt Current	-	-	0	0	192	192	192	-	-	-	0	-
Accrued Liabilities And Other Liabilities	29	22	29	22	38	31	30	18	17	24	20	25
Liabilities Current	47	37	50	48	247	235	236	224	28	30	38	36
Long Term Debt Noncurrent	258	258	258	257	257	257	256	256	447	447	446	446
Other Liabilities Noncurrent	67	69	66	57	60	62	64	71	72	72	72	69
Deferred Income Tax Liabilities Net	37	73	32	-	-	-	0	0	0	4	1	0
Accrued Income Taxes Noncurrent	60	58	57	56	55	54	53	12	-	-	12	-
Stockholders Equity
Preferred Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Value	1	1	1	1	1	1	1	1	1	1	1	1
Treasury Stock Common Value	-	-	-	-	-	-	0	0	0	-394	-394	-394
Additional Paid In Capital Common Stock	860	885	903	904	699	695	692	690	688	1,086	1,093	1,107
Retained Earnings Accumulated Deficit	373	456	269	105	15	-48	-2	-22	-23	11	-25	-87
Stockholders Equity	1,233	1,342	1,173	1,010	715	647	691	669	666	704	675	627
Liabilities And Stockholders Equity	1,703	1,837	1,635	1,429	1,334	1,254	1,301	1,232	1,225	1,268	1,244	1,188
Preferred Stock Par Or Stated Value Per Share	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01
Preferred Stock Shares Authorized	0	0	0	0	0	0	0	0	0	0	0	0
Preferred Stock Shares Issued	0	0	0	0	0	0	0	0	0	0	0	0
Preferred Stock Shares Outstanding	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Par Or Stated Value Per Share	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01
Common Stock Shares Authorized	200	200	200	200	200	200	200	200	200	200	200	200
Common Stock Shares Issued	73	74	75	75	63	63	63	63	63	63	63	64
Shares Outstanding	73	74	75	75	63	63	63	63	63	63	63	64
Treasury Stock Common Shares	-	-	-	-	-	-	0	0	0	32	32	32

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	-4.88%	4.66%	-4.80%	-	-	-	-	-	-	-	-	-
2025	4.43%	6.51%	-0.11%	11.95%	3.34%	-2.96%	19.20%	8.61%	7.30%	-10.48%	0.00%	-9.36%
2024	1.48%	5.40%	19.22%	0.11%	2.76%	6.32%	-4.67%	-11.90%	-6.12%	-3.52%	2.07%	3.80%
2023	-	-	-	-	-	-	11.84%	30.60%	30.92%	-1.24%	-2.16%	4.58%
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Liquidity Ratios
Current Ratio	16.01	21.13	14.64	14.12	2.64	2.48	2.35	1.79	12.70	10.42	9.03	8.43
Quick Ratio	14.66	19.39	13.31	12.93	2.38	2.24	2.12	1.58	11.10	8.61	7.39	6.90
Working Capital	706.30M	736.07M	677.82M	636.10M	405.22M	347.28M	318.22M	176.87M	330.07M	281.46M	306.09M	268.82M
Leverage & Debt
Debt to Equity	0.04	0.03	0.04	0.05	0.34	0.36	0.34	0.33	0.04	0.04	0.06	0.06
Interest Coverage TTM	8.92	9.21	9.81	3.16	3.22	3.26	2.92	8.15	10.82	9.40	11.13	4.96
Debt Ratio	0.03	0.02	0.03	0.03	0.18	0.19	0.18	0.18	0.02	0.02	0.03	0.03
Efficiency & Turnover
Asset Turnover TTM	0.17	0.16	0.16	0.20	0.20	0.20	0.19	0.23	0.22	0.20	0.19	0.22
Per Share Metrics
Diluted EPS TTM	4.87	5.94	3.20	1.50	0.46	-0.95	0.32	1.03	2.33	2.15	2.07	0.58
Free Cash Flow Per Share TTM	2.58	2.45	2.91	2.90	3.19	3.19	3.00	2.59	2.52	2.41	2.15	1.79
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Margin Metrics
Gross Profit Margin TTM	119.80%	126.17%	130.10%	114.21%	121.46%	122.37%	122.54%	74.34%	76.81%	77.46%	80.98%	88.09%
Operating Profit Margin TTM	61.31%	65.27%	69.24%	61.83%	69.72%	72.17%	69.03%	65.78%	87.93%	74.49%	81.26%	25.19%
Net Profit Margin TTM	134.73%	205.15%	114.67%	46.90%	15.26%	-23.62%	9.68%	22.98%	56.17%	75.59%	75.25%	18.42%
Growth Metrics
Net Revenue Growth (1Y)	4.70%	-2.78%	-2.17%	-3.41%	-2.17%	5.37%	1.21%	3.84%	-4.38%	-19.46%	-23.36%	-27.46%
Net Income Growth (1Y)	824.31%	-944.46%	1,059.22%	97.15%	-73.42%	-132.93%	-86.98%	29.50%	-37.68%	-22.15%	-15.99%	-87.39%
EPS Growth (1Y)	691.42%	-814.07%	978.91%	78.63%	-73.57%	-133.18%	-86.42%	34.43%	-34.88%	-16.49%	-10.58%	-86.46%
Valuation Metrics
P/E TTM	4.67	3.43	4.97	9.90	32.68	-19.04	46.52	18.71	7.05	5.31	5.84	16.92
P/B TTM	1.35	1.29	1.15	1.25	1.77	1.76	1.57	1.81	1.54	1.37	1.56	1.34
P/S TTM	6.29	7.03	5.70	4.64	4.99	4.50	4.50	4.30	3.96	4.01	4.39	3.12
Market Cap	1.67B	1.73B	1.35B	1.26B	1.26B	1.14B	1.09B	1.21B	1.03B	962.94M	1.05B	843.74M
Enterprise Value	1.36B	1.38B	1.05B	1.04B	1.31B	1.27B	1.23B	1.40B	1.26B	1.23B	1.30B	1.11B
Calculated Values
Free Cash Flow TTM	189.44M	181.97M	195.80M	200.54M	200.35M	199.99M	188.42M	162.29M	157.59M	152.05M	140.65M	116.41M
Net Debt	-311.93M	-344.99M	-293.21M	-219.14M	51.39M	129.80M	143.38M	187.19M	230.28M	268.40M	252.72M	265.72M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2025-03-06Sale

Owner: Denner, Alexander J, Sari…

Title: -

Shares: 1,196,746

Price/Share: $17.52

Value: $20,966,989.92

Shares Owned: 5,658,705

Relationship: TenPercentOwner

Ownership: Indirect

2023-11-15Sale

Owner: Zhen, Marianne

Title: Chief Accounting Officer

Shares: 10,994

Price/Share: $13.99

Value: $153,806.06

Shares Owned: 40,158

Relationship: Officer

Ownership: Direct

2023-06-15Purchase

Owner: Sarissa, Capital Manageme…

Title: -

Shares: 62,000

Price/Share: $13.13

Value: $814,060.00

Shares Owned: 7,277,000

Relationship: TenPercentOwner

Ownership: Indirect

2023-06-06Purchase

Owner: Denner, Alexander J, Sari…

Title: -

Shares: 8,000

Price/Share: $13.05

Value: $104,400.00

Shares Owned: 7,215,000

Relationship: TenPercentOwner

Ownership: Indirect

2023-05-30Purchase

Owner: Denner, Alexander J, Sari…

Title: -

Shares: 120,000

Price/Share: $13.01

Value: $1,561,200.00

Shares Owned: 7,200,000

Relationship: TenPercentOwner

Ownership: Indirect

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2025-03-06	Denner, Alexander J, Sari…	TenPercentOwner	-	Indirect	Sale	1,196,746	17.52	$20,966,989.92	5,658,705	4
2023-11-15	Zhen, Marianne	Officer	Chief Accounting Officer	Direct	Sale	10,994	13.99	$153,806.06	40,158	4
2023-06-15	Sarissa, Capital Manageme…	TenPercentOwner	-	Indirect	Purchase	62,000	13.13	$814,060.00	7,277,000	4
2023-06-06	Denner, Alexander J, Sari…	TenPercentOwner	-	Indirect	Purchase	8,000	13.05	$104,400.00	7,215,000	4
2023-05-30	Denner, Alexander J, Sari…	TenPercentOwner	-	Indirect	Purchase	120,000	13.01	$1,561,200.00	7,200,000	4
2023-05-19	Sarissa, Capital Manageme…	TenPercentOwner	-	Indirect	Purchase	36,000	13.48	$485,280.00	7,000,000	4/A
2023-05-11	Denner, Alexander J, Sari…	TenPercentOwner	-	Indirect	Purchase	290,000	12.34	$3,578,600.00	6,904,000	4
2023-03-10	Raifeld, Pavel	Officer	Chief Executive Officer	Direct	Purchase	3,000	10.87	$32,610.00	9,799	4
Additional insider transactions are for subscribers only. Unlock the complete Form 4 filing history Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

99.37%

Inst. Shares: 73,695,084

Shares Outstanding: 74,160,000

2025-12-31

109.16%

Inst. Shares: 73,565,148

Shares Outstanding: 67,395,000

2025-09-30

108.18%

Inst. Shares: 74,707,866

Shares Outstanding: 69,058,000

2025-06-30

114.54%

Inst. Shares: 72,002,906

Shares Outstanding: 62,865,000

2025-03-31

105.69%

Inst. Shares: 66,278,988

Shares Outstanding: 62,709,000

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	73,695,084	74,160,000	99.37%
2025-12-31	73,565,148	67,395,000	109.16%
2025-09-30	74,707,866	69,058,000	108.18%
2025-06-30	72,002,906	62,865,000	114.54%
2025-03-31	66,278,988	62,709,000	105.69%
2024-12-31	69,887,477	62,726,000	111.42%
2024-09-30	70,873,209	62,569,000	113.27%
2024-06-30	70,936,973	62,526,000	113.45%
2024-03-31	66,022,203	63,185,000	104.49%
2023-12-31	66,108,746	65,435,000	101.03%
2023-09-30	62,378,156	64,953,000	96.04%
2023-06-30	64,264,738	65,341,000	98.35%
Additional institutional holders are for subscribers only. Unlock the complete Form 13F ownership history Start 7-day free trial

Innoviva, Inc. (INVA) — SEC Financial Statements & Analysis

Innoviva, Inc. (INVA) is a pharmaceutical preparations company, incorporated in DE. Innoviva, Inc. trades on Nasdaq as: INVA. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), Innoviva, Inc. reported a 4.70% year-over-year revenue growth, a Gross Profit Margin of 119.80% (TTM), a Debt-to-Equity ratio of 0.04x, a Price-to-Sales (P/S) ratio of 6.29x (TTM), a Price-to-Book (P/B) ratio of 1.35x (TTM), at a market cap of $1.67B. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y: 4.70%
Gross Profit Margin TTM: 119.80%
Debt To Equity: 0.04x
P/S TTM: 6.29x
P/B TTM: 1.35x
Market Cap: $1.67B

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is Innoviva, Inc. in?

Innoviva, Inc. (INVA) operates in the Pharmaceutical Preparations industry.

What is INVA's market cap?

Innoviva, Inc. (INVA) has a market capitalization of $1.67B as of 2026-06-30.

What is INVA's P/E ratio?

Innoviva, Inc. (INVA)'s trailing twelve month P/E ratio is 4.67x as of 2026-06-30.

What exchange does INVA trade on?

Innoviva, Inc. (INVA) trades on the Nasdaq.

Where is Innoviva, Inc. incorporated?

Innoviva, Inc. is incorporated in DE.

Innoviva, Inc.

Financial Statements

Custom Table

Interactive Financial Visualizations

Earnings Market Reaction

Performance and Valuation Metrics

Insider Transactions

Institutional Ownership

Innoviva, Inc. (INVA) — SEC Financial Statements & Analysis

Frequently Asked Questions

Companies in Pharmaceutical Preparations

Wall Street's data.
Main Street's price.

Innoviva, Inc. (INVA) — SEC Financial Statements & Analysis

Frequently Asked Questions

Companies in Pharmaceutical Preparations

Wall Street's data.Main Street's price.

Wall Street's data.
Main Street's price.